Cancer Biomarkers

The compounds known as cancer biomarkers act as indicators of the presence of cancer in the body. The biomarker, which is often an atom released by the tumour or as a result of the tumor's proximity, is a processable sign of the body's natural state. The biomarkers are used to assess the risk for disease patients. The quantitative way to find the tumour cells is consistently provided by the cancer biomarkers, particularly those specifically associated to hereditary modifications or epigenetic modification. The most valuable feature of a biomarker is its ability to be used as a symptomatic tool to determine if a tumour is localised or has spread to other organs. The biomarkers can also influence the prognosis for cancer.

    Related Conference of Cancer Biomarkers

    August 20-21, 2024

    11th World Summit on Epilepsy and Bipolar Disorders

    Montreal, Canada
    September 26-27, 2024

    7th Annual Congress on Emergency Medicine and Acute Care

    Amsterdam, Netherlands
    October 14-15, 2024

    11th World Machine Learning and Deep learning Conference

    Barcelona, Spain
    October 31-01, 2024

    8th International Conference on Internal Medicine

    Amsterdam, Netherlands
    November 22-23, 2024

    4th International Conference on Medical Research and Development

    Aix-en-Provence, France
    November 25-26, 2024

    10th World Congress on Anesthesia and Critical Care

    Aix-en-Provence, France

    Cancer Biomarkers Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in